person · Reporting owner

Breeden Richard C

Disclosed activity across 2 companies

Tapewire entity: 41365
SEC CIK: 0001300622

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
STERIS plcSTE · Entity 3228	Director	June 02, 2026	June 04, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

STERIS plc

Report date June 02, 2026 · Filed June 04, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Ordinary SharesSEC Table I · non-derivative	Direct	38,964	Ending reported balance After 2026-06-02 transaction · row 2 2 source rows · reconciled sequence Row 1 · 2026-06-02 · Exercise / conversion · Acquired 3,781 · Balance 40,445 Row 2 · 2026-06-02 · Sale · Disposed 1,481 · Balance 38,964 F1: Price reflects a weighted average sale price for multiple transactions ranging from $209.50 to $209.53 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $71.40 · Expires 2026-08-10	Direct	0	Reported balance After 2026-06-02 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2026-06-02 · Exercise / conversion · Disposed 3,781 · Balance 0 F4: This option to purchase 3,781 STERIS plc ordinary shares, which is fully vested, was received in connection with the redomiciliation of STERIS plc to Ireland in March 2019 in exchange for an option to purchase 3,781 ordinary shares for $71.40 per share in STERIS plc prior to the redomiciliation ("Old STERIS"), subject to the same terms and conditions as the original Old STERIS stock option.
Ordinary SharesSEC Table I · non-derivative	IndirectSee Footnotes Below	27,242	Reported balance Holding disclosure · report date 2026-06-02 · row 3 Holding and transaction disclosures are not merged. 1 source row Row 3 · Balance 27,242 F2: Richard C. Breeden is the managing member of Breeden Capital Partners LLC, and managing member and chairman and chief executive officer of Breeden Capital Management LLC. Breeden Capital Partners LLC (the "General Partner") is in turn the general partner of Breeden Partners L.P. (the "Fund"). F3: Pursuant to Rule 16a-1(a)(2)(ii)(B) of the Securities Exchange Act of 1934, as amended, Mr. Breeden in his capacity as managing member, as well as chairman and chief executive officer of Breeden Capital Management LLC and as the managing member of Breeden Capital Partners LLC, may be deemed to be the indirect beneficial owner of the ordinary shares owned by the Fund and its General Partner, and may be deemed to have beneficial ownership of all such shares. Mr. Breeden disclaims beneficial ownership over 1,358 of these shares held by Breeden Partnership LLP.

Filing footnotes · ownership attribution and instrument terms

F1: Price reflects a weighted average sale price for multiple transactions ranging from $209.50 to $209.53 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F2: Richard C. Breeden is the managing member of Breeden Capital Partners LLC, and managing member and chairman and chief executive officer of Breeden Capital Management LLC. Breeden Capital Partners LLC (the "General Partner") is in turn the general partner of Breeden Partners L.P. (the "Fund").

F3: Pursuant to Rule 16a-1(a)(2)(ii)(B) of the Securities Exchange Act of 1934, as amended, Mr. Breeden in his capacity as managing member, as well as chairman and chief executive officer of Breeden Capital Management LLC and as the managing member of Breeden Capital Partners LLC, may be deemed to be the indirect beneficial owner of the ordinary shares owned by the Fund and its General Partner, and may be deemed to have beneficial ownership of all such shares. Mr. Breeden disclaims beneficial ownership over 1,358 of these shares held by Breeden Partnership LLP.

F4: This option to purchase 3,781 STERIS plc ordinary shares, which is fully vested, was received in connection with the redomiciliation of STERIS plc to Ireland in March 2019 in exchange for an option to purchase 3,781 ordinary shares for $71.40 per share in STERIS plc prior to the redomiciliation ("Old STERIS"), subject to the same terms and conditions as the original Old STERIS stock option.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

STERIS plc

Report date March 28, 2019 · Filed March 28, 2019

Section 16 reporting ended · disclosed 2019-03-28. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosure context
Ordinary Shares, 10 pence par valueSEC Table I · non-derivative	Direct	Reported balance After 2019-03-28 transaction · row 1 1 source row Row 1 · 2019-03-28 · Disposition to issuer · Disposed 28,548 · Balance 0 F1: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"), cancelled pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS"), in an amount equal to the number of the reporting person's cancelled Old STERIS shares. The reporting person's STERIS shares will be subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS.
Ordinary Shares, 10 pence par valueSEC Table I · non-derivative	IndirectSee Footnote Below.	Reported balance After 2019-03-28 transaction · row 2 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 2 · 2019-03-28 · Disposition to issuer · Disposed 72,242 · Balance 0 F1: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"), cancelled pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS"), in an amount equal to the number of the reporting person's cancelled Old STERIS shares. The reporting person's STERIS shares will be subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS. F2: Richard C. Breeden is the managing member of Breeden Capital Partners LLC, managing member and chairman and chief executive officer of Breeden Capital Management LLC. Breeden Capital Partners LLC is in turn the general partner of Breeden Partners L.P. (the "Fund"). F3: Pursuant to Rule 16a-1(a)(2)(ii)(B) of the Securities Exchange Act of 1934, as amended, Mr. Breeden in his capacity as managing member, as well as chairman and chief executive officer of Breeden Capital Management LLC and as the managing member of Breeden Capital Partners LLC, may be deemed to be the indirect beneficial owner of the ordinary shares owned by the Fund and its General Partner, and may be deemed to have beneficial ownership of all such shares.
Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $32.34 · Expires 2020-08-04	Direct	Reported balance After 2019-03-28 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2019-03-28 · Disposition to issuer · Disposed 3,133 · Balance 0 F4: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,133 ordinary shares of STERIS for $32.34 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $31.61 · Expires 2021-08-03	Direct	Reported balance After 2019-03-28 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2019-03-28 · Disposition to issuer · Disposed 3,121 · Balance 0 F5: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,121 ordinary shares of STERIS for $31.61 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $32.36 · Expires 2022-08-03	Direct	Reported balance After 2019-03-28 transaction · row 5 Instrument identity requires review; Table II rows are not merged. 1 source row Row 5 · 2019-03-28 · Disposition to issuer · Disposed 3,218 · Balance 0 F6: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,218 ordinary shares of STERIS for $32.36 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $43.92 · Expires 2023-08-08	Direct	Reported balance After 2019-03-28 transaction · row 6 Instrument identity requires review; Table II rows are not merged. 1 source row Row 6 · 2019-03-28 · Disposition to issuer · Disposed 4,657 · Balance 0 F7: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 4,657 ordinary shares of STERIS for $43.92 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $51.53 · Expires 2024-08-06	Direct	Reported balance After 2019-03-28 transaction · row 7 Instrument identity requires review; Table II rows are not merged. 1 source row Row 7 · 2019-03-28 · Disposition to issuer · Disposed 4,584 · Balance 0 F8: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 4,584 ordinary shares of STERIS for $51.53 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $64.05 · Expires 2025-08-31	Direct	Reported balance After 2019-03-28 transaction · row 8 Instrument identity requires review; Table II rows are not merged. 1 source row Row 8 · 2019-03-28 · Disposition to issuer · Disposed 4,110 · Balance 0 F9: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 4,110 ordinary shares of STERIS for $64.05 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $71.40 · Expires 2026-08-10	Direct	Reported balance After 2019-03-28 transaction · row 9 Instrument identity requires review; Table II rows are not merged. 1 source row Row 9 · 2019-03-28 · Disposition to issuer · Disposed 3,781 · Balance 0 F10: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,781 ordinary shares of STERIS for $71.40 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $86.23 · Expires 2027-08-09	Direct	Reported balance After 2019-03-28 transaction · row 10 Instrument identity requires review; Table II rows are not merged. 1 source row Row 10 · 2019-03-28 · Disposition to issuer · Disposed 4,058 · Balance 0 F11: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 4,058 ordinary shares of STERIS for $86.23 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $114.74 · Expires 2028-08-09	Direct	Reported balance After 2019-03-28 transaction · row 11 Instrument identity requires review; Table II rows are not merged. 1 source row Row 11 · 2019-03-28 · Disposition to issuer · Disposed 3,495 · Balance 0 F12: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,495 ordinary shares of STERIS for $114.74 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
Career Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	Reported balance After 2019-03-28 transaction · row 12 Instrument identity requires review; Table II rows are not merged. 1 source row Row 12 · 2019-03-28 · Disposition to issuer · Disposed 12,716 · Balance 0 F13: These career restricted stock units were assumed by STERIS pursuant to the Scheme and converted to career restricted stock units of STERIS representing the right to receive 12,716 STERIS ordinary shares. These career restricted stock units are fully vested and will be settled in STERIS ordinary shares six months after the cessation of the reporting person's board service, subject to the terms and conditions of the award agreement.

Filing footnotes · ownership attribution and instrument terms

F1: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"), cancelled pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS"), in an amount equal to the number of the reporting person's cancelled Old STERIS shares. The reporting person's STERIS shares will be subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS.

F2: Richard C. Breeden is the managing member of Breeden Capital Partners LLC, managing member and chairman and chief executive officer of Breeden Capital Management LLC. Breeden Capital Partners LLC is in turn the general partner of Breeden Partners L.P. (the "Fund").

F4: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,133 ordinary shares of STERIS for $32.34 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.

F5: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,121 ordinary shares of STERIS for $31.61 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.

F6: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,218 ordinary shares of STERIS for $32.36 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.

F7: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 4,657 ordinary shares of STERIS for $43.92 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.

F8: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 4,584 ordinary shares of STERIS for $51.53 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.

F9: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 4,110 ordinary shares of STERIS for $64.05 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.

F10: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,781 ordinary shares of STERIS for $71.40 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.

F11: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 4,058 ordinary shares of STERIS for $86.23 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.

F12: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,495 ordinary shares of STERIS for $114.74 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.

F13: These career restricted stock units were assumed by STERIS pursuant to the Scheme and converted to career restricted stock units of STERIS representing the right to receive 12,716 STERIS ordinary shares. These career restricted stock units are fully vested and will be settled in STERIS ordinary shares six months after the cessation of the reporting person's board service, subject to the terms and conditions of the award agreement.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
June 02, 2026 Filed Jun 4, 2026 20:31 UTC	STERIS plc STE · Entity 3228	Exercise / conversionEmployee Stock Option (right to buy) · Derivative	3,781	$0.00 Strike: $71.40	$0.00	Disclosure SEC source: 0001628280-26-040830 · wk-form4_1780605065.xml · derivative · entry 4 Breeden Richard C · CIK 0001300622 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 3,781 shares Expires 2026-08-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option to purchase 3,781 STERIS plc ordinary shares, which is fully vested, was received in connection with the redomiciliation of STERIS plc to Ireland in March 2019 in exchange for an option to purchase 3,781 ordinary shares for $71.40 per share in STERIS plc prior to the redomiciliation ("Old STERIS"), subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document
June 02, 2026 Filed Jun 4, 2026 20:31 UTC	STERIS plc STE · Entity 3228	SaleOrdinary Shares	1,481	$209.51	$310,284.31	Disclosure SEC source: 0001628280-26-040830 · wk-form4_1780605065.xml · nonDerivative · entry 2 Breeden Richard C · CIK 0001300622 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,964 F1 · price: Price reflects a weighted average sale price for multiple transactions ranging from $209.50 to $209.53 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document
June 02, 2026 Filed Jun 4, 2026 20:31 UTC	STERIS plc STE · Entity 3228	Exercise / conversionOrdinary Shares	3,781	$71.40	$269,963.40	Disclosure SEC source: 0001628280-26-040830 · wk-form4_1780605065.xml · nonDerivative · entry 1 Breeden Richard C · CIK 0001300622 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,445 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
August 13, 2025 Filed Aug 15, 2025 20:31 UTC	STERIS plc STE · Entity 3228	Exercise / conversionDirector Stock Option (right to buy) · Derivative	4,110	$0.00 Strike: $64.05	$0.00	Disclosure SEC source: 0001628280-25-040522 · wk-form4_1755289866.xml · derivative · entry 3 Breeden Richard C · CIK 0001300622 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 4,110 shares Expires 2025-08-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option to purchase 4,110 STERIS plc ordinary shares, which is fully vested, was received in connection with the redomiciliation of STERIS plc to Ireland in March 2019 in exchange for an option to purchase 4,110 ordinary shares for $64.05 per share in STERIS plc prior to the redomiciliation ("Old STERIS"), subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document
August 13, 2025 Filed Aug 15, 2025 20:31 UTC	STERIS plc STE · Entity 3228	Exercise / conversionOrdinary Shares	4,110	$64.05	$263,245.50	Disclosure SEC source: 0001628280-25-040522 · wk-form4_1755289866.xml · nonDerivative · entry 1 Breeden Richard C · CIK 0001300622 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,664 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
August 08, 2025 Filed Aug 12, 2025 21:25 UTC	STERIS plc STE · Entity 3228	GrantCareer Restricted Stock Units · Derivative	355	$242.85	$86,211.75	Disclosure SEC source: 0001628280-25-039968 · wk-form4_1755033926.xml · derivative · entry 4 Breeden Richard C · CIK 0001300622 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,545 Underlying: Ordinary Shares · 355 shares Expires not disclosed F3 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F5 · price: These Career Restricted Stock Units were issued to the Reporting Person in lieu of $86,000 in fees. F4 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F4 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document
August 08, 2025 Filed Aug 12, 2025 21:25 UTC	STERIS plc STE · Entity 3228	GrantCareer Restricted Stock Units · Derivative	487	$0.00	$0.00	Disclosure SEC source: 0001628280-25-039968 · wk-form4_1755033926.xml · derivative · entry 3 Breeden Richard C · CIK 0001300622 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,190 Underlying: Ordinary Shares · 487 shares Expires not disclosed F3 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F4 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F4 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document
August 08, 2025 Filed Aug 12, 2025 21:25 UTC	STERIS plc STE · Entity 3228	GrantDirector Stock Option (right to buy) · Derivative	297	$84.20 Strike: $242.85	$25,007.40	Disclosure SEC source: 0001628280-25-039968 · wk-form4_1755033926.xml · derivative · entry 2 Breeden Richard C · CIK 0001300622 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,704 Underlying: Ordinary Shares · 297 shares Expires 2035-08-08 F2 · derivative.exercise_price: These nonqualified stock options were issued to the Reporting Person in lieu of $25,000 in fees. F1 · derivative.exercise_date: These nonqualified stock options are fully vested and are exercisable immediately. Read SEC document
August 08, 2025 Filed Aug 12, 2025 21:25 UTC	STERIS plc STE · Entity 3228	GrantDirector Stock Option (right to buy) · Derivative	1,407	$0.00 Strike: $242.85	$0.00	Disclosure SEC source: 0001628280-25-039968 · wk-form4_1755033926.xml · derivative · entry 1 Breeden Richard C · CIK 0001300622 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,407 Underlying: Ordinary Shares · 1,407 shares Expires 2035-08-08 F1 · derivative.exercise_date: These nonqualified stock options are fully vested and are exercisable immediately. Read SEC document
August 08, 2024 Filed Aug 12, 2024 20:32 UTC	STERIS plc STE · Entity 3228	GrantCareer Restricted Stock Units · Derivative	358	$239.68	$85,805.44	Disclosure SEC source: 0001628280-24-036785 · wk-form4_1723494771.xml · derivative · entry 4 Breeden Richard C · CIK 0001300622 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,703 Underlying: Ordinary Shares · 358 shares Expires not disclosed F3 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F5 · price: These Career Restricted Stock Units were issued to the Reporting Person in lieu of fees of $86,000. F4 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F4 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document
August 08, 2024 Filed Aug 12, 2024 20:32 UTC	STERIS plc STE · Entity 3228	GrantCareer Restricted Stock Units · Derivative	495	$0.00	$0.00	Disclosure SEC source: 0001628280-24-036785 · wk-form4_1723494771.xml · derivative · entry 3 Breeden Richard C · CIK 0001300622 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,345 Underlying: Ordinary Shares · 495 shares Expires not disclosed F3 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F4 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F4 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document
August 08, 2024 Filed Aug 12, 2024 20:32 UTC	STERIS plc STE · Entity 3228	GrantDirector Stock Option (right to buy) · Derivative	292	$85.34 Strike: $239.68	$24,919.28	Disclosure SEC source: 0001628280-24-036785 · wk-form4_1723494771.xml · derivative · entry 2 Breeden Richard C · CIK 0001300622 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,681 Underlying: Ordinary Shares · 292 shares Expires 2034-08-08 F2 · derivative.exercise_price: These nonqualified stock options were issued to the Reporting Person in lieu of fees of $25,000. F1 · derivative.exercise_date: These nonqualified stock options are fully vested and are exercisable immediately. Read SEC document
August 08, 2024 Filed Aug 12, 2024 20:32 UTC	STERIS plc STE · Entity 3228	GrantDirector Stock Option (right to buy) · Derivative	1,389	$0.00 Strike: $239.68	$0.00	Disclosure SEC source: 0001628280-24-036785 · wk-form4_1723494771.xml · derivative · entry 1 Breeden Richard C · CIK 0001300622 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,389 Underlying: Ordinary Shares · 1,389 shares Expires 2034-08-08 F1 · derivative.exercise_date: These nonqualified stock options are fully vested and are exercisable immediately. Read SEC document
May 21, 2024 Filed May 23, 2024 20:34 UTC	STERIS plc STE · Entity 3228	Exercise / conversionDirector Stock Option (right to buy) · Derivative	4,584	$0.00 Strike: $51.53	$0.00	Disclosure SEC source: 0001628280-24-024972 · wk-form4_1716496445.xml · derivative · entry 3 Breeden Richard C · CIK 0001300622 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 4,584 shares Expires 2024-08-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option to purchase 4,584 STERIS plc ordinary shares, which is fully vested, was received in connection with the redomiciliation of STERIS plc to Ireland in March 2019 in exchange for an option to purchase 4,584 ordinary shares for $51.53 per share in STERIS plc prior to the redomiciliation ("Old STERIS"), subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document
May 21, 2024 Filed May 23, 2024 20:34 UTC	STERIS plc STE · Entity 3228	Exercise / conversionOrdinary Shares	4,584	$51.53	$236,213.52	Disclosure SEC source: 0001628280-24-024972 · wk-form4_1716496445.xml · nonDerivative · entry 1 Breeden Richard C · CIK 0001300622 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,554 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
August 03, 2023 Filed Aug 7, 2023 20:35 UTC	STERIS plc STE · Entity 3228	GrantCareer Restricted Stock Units · Derivative	364	$225.50	$82,082.00	Disclosure SEC source: 0001209191-23-044821 · doc4.xml · derivative · entry 4 Breeden Richard C · CIK 0001300622 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,850 Underlying: Ordinary Shares · 364 shares Expires not disclosed F3 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F5 · price: These Career Restricted Stock Units were issued to the Reporting Person in lieu of $82,000 in fees. F4 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F4 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document
August 03, 2023 Filed Aug 7, 2023 20:35 UTC	STERIS plc STE · Entity 3228	GrantCareer Restricted Stock Units · Derivative	525	$0.00	$0.00	Disclosure SEC source: 0001209191-23-044821 · doc4.xml · derivative · entry 3 Breeden Richard C · CIK 0001300622 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,486 Underlying: Ordinary Shares · 525 shares Expires not disclosed F3 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F4 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F4 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document
August 03, 2023 Filed Aug 7, 2023 20:35 UTC	STERIS plc STE · Entity 3228	GrantDirector Stock Option (right to buy) · Derivative	326	$76.72 Strike: $225.50	$25,010.72	Disclosure SEC source: 0001209191-23-044821 · doc4.xml · derivative · entry 2 Breeden Richard C · CIK 0001300622 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,870 Underlying: Ordinary Shares · 326 shares Expires 2033-08-03 F2 · derivative.exercise_price: These nonqualified stock options were issued to the Reporting Person in lieu of fees of $25,000. F1 · derivative.exercise_date: These nonqualified stock options are fully vested and are exercisable immediately. Read SEC document
August 03, 2023 Filed Aug 7, 2023 20:35 UTC	STERIS plc STE · Entity 3228	GrantDirector Stock Option (right to buy) · Derivative	1,544	$0.00 Strike: $225.50	$0.00	Disclosure SEC source: 0001209191-23-044821 · doc4.xml · derivative · entry 1 Breeden Richard C · CIK 0001300622 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,544 Underlying: Ordinary Shares · 1,544 shares Expires 2033-08-03 F1 · derivative.exercise_date: These nonqualified stock options are fully vested and are exercisable immediately. Read SEC document
May 16, 2023 Filed May 18, 2023 20:35 UTC	STERIS plc STE · Entity 3228	SaleOrdinary Shares	12,130	$208.61	$2,530,439.30	Disclosure SEC source: 0001209191-23-030651 · doc4.xml · nonDerivative · entry 1 Breeden Richard C · CIK 0001300622 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,970 F1 · price: Price reflects a weighted average sale price for multiple transactions ranging from $208.50 to $209.33 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document
May 15, 2023 Filed May 16, 2023 20:35 UTC	STERIS plc STE · Entity 3228	SaleOrdinary Shares	2,737	$211.00	$577,507.00	Disclosure SEC source: 0001209191-23-029814 · doc4.xml · nonDerivative · entry 1 Breeden Richard C · CIK 0001300622 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,100 F1 · price: Price reflects a weighted average sale price for multiple transactions ranging from $211.00 to $211.02 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document
February 15, 2023 Filed Feb 17, 2023 21:35 UTC	STERIS plc STE · Entity 3228	Exercise / conversionDirector Stock Option (right to buy) · Derivative	4,657	Not disclosed Strike: $43.92	Not disclosed	Disclosure SEC source: 0001209191-23-010662 · doc4.xml · derivative · entry 3 Breeden Richard C · CIK 0001300622 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 4,657 shares Expires 2023-08-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: This option to purchase 4,657 STERIS plc ordinary shares, which is fully vested, was received in connection with the redomiciliation of STERIS plc to Ireland in March 2019 in exchange for an option to purchase 4,657 ordinary shares for $43.92 per share in STERIS plc prior to the redomiciliation ("Old STERIS"), subject to the same terms and conditions as the original Old STERIS stock option. F3 · derivative.exercise_date: This option to purchase 4,657 STERIS plc ordinary shares, which is fully vested, was received in connection with the redomiciliation of STERIS plc to Ireland in March 2019 in exchange for an option to purchase 4,657 ordinary shares for $43.92 per share in STERIS plc prior to the redomiciliation ("Old STERIS"), subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document
February 15, 2023 Filed Feb 17, 2023 21:35 UTC	STERIS plc STE · Entity 3228	Exercise / conversionOrdinary Shares	4,657	$43.92	$204,535.44	Disclosure SEC source: 0001209191-23-010662 · doc4.xml · nonDerivative · entry 1 Breeden Richard C · CIK 0001300622 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,837 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
August 03, 2022 Filed Aug 5, 2022 20:36 UTC	STERIS plc STE · Entity 3228	GrantCareer Restricted Stock Units · Derivative	404	$203.00	$82,012.00	Disclosure SEC source: 0001209191-22-044576 · doc4.xml · derivative · entry 4 Breeden Richard C · CIK 0001300622 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,961 Underlying: Ordinary Shares · 404 shares Expires not disclosed F3 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F5 · price: These Career Restricted Stock Units were issued to the Reporting Person in lieu of fees of $82,000. F4 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F4 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document
August 03, 2022 Filed Aug 5, 2022 20:36 UTC	STERIS plc STE · Entity 3228	GrantCareer Restricted Stock Units · Derivative	573	$0.00	$0.00	Disclosure SEC source: 0001209191-22-044576 · doc4.xml · derivative · entry 3 Breeden Richard C · CIK 0001300622 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,557 Underlying: Ordinary Shares · 573 shares Expires not disclosed F3 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F4 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F4 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document
August 03, 2022 Filed Aug 5, 2022 20:36 UTC	STERIS plc STE · Entity 3228	GrantDirector Stock Option (right to buy) · Derivative	401	$62.32 Strike: $203.00	$24,990.32	Disclosure SEC source: 0001209191-22-044576 · doc4.xml · derivative · entry 2 Breeden Richard C · CIK 0001300622 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,270 Underlying: Ordinary Shares · 401 shares Expires 2032-08-03 F2 · derivative.exercise_price: These nonqualified stock options were issued to the Reporting Person in lieu of fees of $25,000. F1 · derivative.exercise_date: These nonqualified stock options are fully vested and are exercisable immediately. Read SEC document
August 03, 2022 Filed Aug 5, 2022 20:36 UTC	STERIS plc STE · Entity 3228	GrantDirector Stock Option (right to buy) · Derivative	1,869	$0.00 Strike: $203.00	$0.00	Disclosure SEC source: 0001209191-22-044576 · doc4.xml · derivative · entry 1 Breeden Richard C · CIK 0001300622 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,869 Underlying: Ordinary Shares · 1,869 shares Expires 2032-08-03 F1 · derivative.exercise_date: These nonqualified stock options are fully vested and are exercisable immediately. Read SEC document
June 02, 2022 Filed Jun 6, 2022 20:35 UTC	STERIS plc STE · Entity 3228	Exercise / conversionDirector Stock Option (right to buy) · Derivative	3,218	Not disclosed Strike: $32.36	Not disclosed	Disclosure SEC source: 0001209191-22-034534 · doc4.xml · derivative · entry 3 Breeden Richard C · CIK 0001300622 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 3,218 shares Expires 2022-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: This option to purchase 3,218 STERIS plc ordinary shares, which is fully vested, was received in connection with the redomiciliation of STERIS plc to Ireland in March 2019 in exchange for an option to purchase 3,218 ordinary shares for $32.36 per share in STERIS plc prior to the redomiciliation ("Old STERIS"), subject to the same terms and conditions as the original Old STERIS stock option. F3 · derivative.exercise_date: This option to purchase 3,218 STERIS plc ordinary shares, which is fully vested, was received in connection with the redomiciliation of STERIS plc to Ireland in March 2019 in exchange for an option to purchase 3,218 ordinary shares for $32.36 per share in STERIS plc prior to the redomiciliation ("Old STERIS"), subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document
June 02, 2022 Filed Jun 6, 2022 20:35 UTC	STERIS plc STE · Entity 3228	Exercise / conversionOrdinary Shares	3,218	$32.36	$104,134.48	Disclosure SEC source: 0001209191-22-034534 · doc4.xml · nonDerivative · entry 1 Breeden Richard C · CIK 0001300622 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,180 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
August 10, 2021 Filed Aug 12, 2021 20:32 UTC	STERIS plc STE · Entity 3228	GrantCareer Restricted Stock Units · Derivative	376	$217.62	$81,825.12	Disclosure SEC source: 0001209191-21-051112 · doc4.xml · derivative · entry 4 Breeden Richard C · CIK 0001300622 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,984 Underlying: Ordinary Shares · 376 shares Expires not disclosed F3 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F5 · price: These Career Restricted Stock Units were issued to the Reporting Person in lieu of fees of $82,000. F4 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F4 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document
August 10, 2021 Filed Aug 12, 2021 20:32 UTC	STERIS plc STE · Entity 3228	GrantCareer Restricted Stock Units · Derivative	508	$0.00	$0.00	Disclosure SEC source: 0001209191-21-051112 · doc4.xml · derivative · entry 3 Breeden Richard C · CIK 0001300622 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,608 Underlying: Ordinary Shares · 508 shares Expires not disclosed F3 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F4 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F4 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document
August 10, 2021 Filed Aug 12, 2021 20:32 UTC	STERIS plc STE · Entity 3228	GrantDirector Stock Option (right to buy) · Derivative	471	$53.08 Strike: $217.62	$25,000.68	Disclosure SEC source: 0001209191-21-051112 · doc4.xml · derivative · entry 2 Breeden Richard C · CIK 0001300622 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,498 Underlying: Ordinary Shares · 471 shares Expires 2031-08-10 F2 · derivative.exercise_price: These nonqualified stock options were issued to the Reporting Person in lieu of fees of $25,000. F1 · derivative.exercise_date: These nonqualified stock options are fully vested and are exercisable immediately. Read SEC document
August 10, 2021 Filed Aug 12, 2021 20:32 UTC	STERIS plc STE · Entity 3228	GrantDirector Stock Option (right to buy) · Derivative	2,027	$0.00 Strike: $217.62	$0.00	Disclosure SEC source: 0001209191-21-051112 · doc4.xml · derivative · entry 1 Breeden Richard C · CIK 0001300622 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,027 Underlying: Ordinary Shares · 2,027 shares Expires 2031-08-10 F1 · derivative.exercise_date: These nonqualified stock options are fully vested and are exercisable immediately. Read SEC document
June 02, 2021 Filed Jun 4, 2021 20:34 UTC	STERIS plc STE · Entity 3228	GrantOrdinary Shares	160	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-21-038255 · doc4.xml · nonDerivative · entry 1 Breeden Richard C · CIK 0001300622 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,962 F1 · price: Received in exchange for 475 shares of Cantel Medical Corp. ("Cantel") common stock in connection with the acquisition of Cantel by STERIS plc ("STERIS") pursuant to a series of transactions ("Mergers"). Holders of Cantel common stock received $16.93 in cash and 0.33787 STERIS ordinary shares per Cantel share outstanding immediately prior to the Mergers. Read SEC document
May 27, 2021 Filed May 27, 2021 20:39 UTC	STERIS plc STE · Entity 3228	Exercise / conversionEmployee Stock Option (right to buy) · Derivative	3,121	$0.00 Strike: $31.61	$0.00	Disclosure SEC source: 0001209191-21-036259 · doc4.xml · derivative · entry 3 Breeden Richard C · CIK 0001300622 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 3,121 shares Expires 2021-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option to purchase 3,121 STERIS ordinary shares, which is fully vested, was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 3,121 Old STERIS ordinary shares for $31.61 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. Read SEC document
May 27, 2021 Filed May 27, 2021 20:39 UTC	STERIS plc STE · Entity 3228	Exercise / conversionOrdinary Shares	3,121	$31.61	$98,654.81	Disclosure SEC source: 0001209191-21-036259 · doc4.xml · nonDerivative · entry 1 Breeden Richard C · CIK 0001300622 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,802 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
August 25, 2020 Filed Aug 26, 2020 20:33 UTC	STERIS plc STE · Entity 3228	SaleOrdinary Shares	506	$154.94	$78,399.64	Disclosure SEC source: 0001209191-20-048397 · doc4.xml · nonDerivative · entry 5 Breeden Richard C · CIK 0001300622 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Below Disclosed balance after: 27,242 F7 · price: Price reflects a weighted average sale price for multiple transactions ranging from $154.86 to $155.055 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F2 · ownership.nature: Richard C. Breeden is the managing member of Breeden Capital Partners LLC, and managing member and chairman and chief executive officer of Breeden Capital Management LLC. Breeden Capital Partners LLC is in turn the general partner of Breeden Partners L.P. (the "Fund"). F3 · ownership.nature: Pursuant to Rule 16a-1(a)(2)(ii)(B) of the Securities Exchange Act of 1934, as amended, Mr. Breeden in his capacity as managing member, as well as chairman and chief executive officer of Breeden Capital Management LLC and as the managing member of Breeden Capital Partners LLC, may be deemed to be the indirect beneficial owner of the ordinary shares owned by the Fund and its General Partner, and may be deemed to have beneficial ownership of all such shares. Read SEC document
August 25, 2020 Filed Aug 26, 2020 20:33 UTC	STERIS plc STE · Entity 3228	SaleOrdinary Shares	19,494	$154.36	$3,009,093.84	Disclosure SEC source: 0001209191-20-048397 · doc4.xml · nonDerivative · entry 4 Breeden Richard C · CIK 0001300622 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Below Disclosed balance after: 27,748 F6 · price: Price reflects a weighted average sale price for multiple transactions ranging from $153.83 to $154.785 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F2 · ownership.nature: Richard C. Breeden is the managing member of Breeden Capital Partners LLC, and managing member and chairman and chief executive officer of Breeden Capital Management LLC. Breeden Capital Partners LLC is in turn the general partner of Breeden Partners L.P. (the "Fund"). F3 · ownership.nature: Pursuant to Rule 16a-1(a)(2)(ii)(B) of the Securities Exchange Act of 1934, as amended, Mr. Breeden in his capacity as managing member, as well as chairman and chief executive officer of Breeden Capital Management LLC and as the managing member of Breeden Capital Partners LLC, may be deemed to be the indirect beneficial owner of the ordinary shares owned by the Fund and its General Partner, and may be deemed to have beneficial ownership of all such shares. Read SEC document
August 24, 2020 Filed Aug 26, 2020 20:33 UTC	STERIS plc STE · Entity 3228	SaleOrdinary Shares	946	$154.32	$145,986.72	Disclosure SEC source: 0001209191-20-048397 · doc4.xml · nonDerivative · entry 3 Breeden Richard C · CIK 0001300622 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Below Disclosed balance after: 47,242 F5 · price: Price reflects a weighted average sale price for multiple transactions ranging from $154.12 to $154.56 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F2 · ownership.nature: Richard C. Breeden is the managing member of Breeden Capital Partners LLC, and managing member and chairman and chief executive officer of Breeden Capital Management LLC. Breeden Capital Partners LLC is in turn the general partner of Breeden Partners L.P. (the "Fund"). F3 · ownership.nature: Pursuant to Rule 16a-1(a)(2)(ii)(B) of the Securities Exchange Act of 1934, as amended, Mr. Breeden in his capacity as managing member, as well as chairman and chief executive officer of Breeden Capital Management LLC and as the managing member of Breeden Capital Partners LLC, may be deemed to be the indirect beneficial owner of the ordinary shares owned by the Fund and its General Partner, and may be deemed to have beneficial ownership of all such shares. Read SEC document
August 24, 2020 Filed Aug 26, 2020 20:33 UTC	STERIS plc STE · Entity 3228	SaleOrdinary Shares	4,307	$153.33	$660,392.31	Disclosure SEC source: 0001209191-20-048397 · doc4.xml · nonDerivative · entry 2 Breeden Richard C · CIK 0001300622 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Below Disclosed balance after: 48,188 F4 · price: Price reflects a weighted average sale price for multiple transactions ranging from $152.94 to $153.91 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F2 · ownership.nature: Richard C. Breeden is the managing member of Breeden Capital Partners LLC, and managing member and chairman and chief executive officer of Breeden Capital Management LLC. Breeden Capital Partners LLC is in turn the general partner of Breeden Partners L.P. (the "Fund"). F3 · ownership.nature: Pursuant to Rule 16a-1(a)(2)(ii)(B) of the Securities Exchange Act of 1934, as amended, Mr. Breeden in his capacity as managing member, as well as chairman and chief executive officer of Breeden Capital Management LLC and as the managing member of Breeden Capital Partners LLC, may be deemed to be the indirect beneficial owner of the ordinary shares owned by the Fund and its General Partner, and may be deemed to have beneficial ownership of all such shares. Read SEC document
August 24, 2020 Filed Aug 26, 2020 20:33 UTC	STERIS plc STE · Entity 3228	SaleOrdinary Shares	19,747	$152.45	$3,010,430.15	Disclosure SEC source: 0001209191-20-048397 · doc4.xml · nonDerivative · entry 1 Breeden Richard C · CIK 0001300622 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Below Disclosed balance after: 52,495 F1 · price: Price reflects a weighted average sale price for multiple transactions ranging from $151.885 to $152.86 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F2 · ownership.nature: Richard C. Breeden is the managing member of Breeden Capital Partners LLC, and managing member and chairman and chief executive officer of Breeden Capital Management LLC. Breeden Capital Partners LLC is in turn the general partner of Breeden Partners L.P. (the "Fund"). F3 · ownership.nature: Pursuant to Rule 16a-1(a)(2)(ii)(B) of the Securities Exchange Act of 1934, as amended, Mr. Breeden in his capacity as managing member, as well as chairman and chief executive officer of Breeden Capital Management LLC and as the managing member of Breeden Capital Partners LLC, may be deemed to be the indirect beneficial owner of the ordinary shares owned by the Fund and its General Partner, and may be deemed to have beneficial ownership of all such shares. Read SEC document
August 04, 2020 Filed Aug 6, 2020 20:28 UTC	STERIS plc STE · Entity 3228	GrantCareer Restricted Stock Units · Derivative	658	$0.00	$0.00	Disclosure SEC source: 0001209191-20-045467 · doc4.xml · derivative · entry 3 Breeden Richard C · CIK 0001300622 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,100 Underlying: Ordinary Shares · 658 shares Expires not disclosed F2 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F3 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F3 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document
August 04, 2020 Filed Aug 6, 2020 20:28 UTC	STERIS plc STE · Entity 3228	GrantCareer Restricted Stock Units · Derivative	519	$158.00	$82,002.00	Disclosure SEC source: 0001209191-20-045467 · doc4.xml · derivative · entry 2 Breeden Richard C · CIK 0001300622 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,442 Underlying: Ordinary Shares · 519 shares Expires not disclosed F2 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F4 · price: These Career Restricted Stock Units were issued to the Reporting Person in lieu of fees of $82,000. F3 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F3 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document
August 04, 2020 Filed Aug 6, 2020 20:28 UTC	STERIS plc STE · Entity 3228	GrantDirector Stock Option (right to buy) · Derivative	3,106	$0.00 Strike: $158.00	$0.00	Disclosure SEC source: 0001209191-20-045467 · doc4.xml · derivative · entry 1 Breeden Richard C · CIK 0001300622 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,106 Underlying: Ordinary Shares · 3,106 shares Expires 2030-08-04 F1 · derivative.exercise_date: These nonqualified stock options are fully vested and are exercisable immediately. Read SEC document
March 05, 2020 Filed Mar 6, 2020 21:31 UTC	STERIS plc STE · Entity 3228	Exercise / conversionDirector Stock Option (right to buy) · Derivative	3,133	$0.00 Strike: $32.34	$0.00	Disclosure SEC source: 0001209191-20-016928 · doc4.xml · derivative · entry 3 Breeden Richard C · CIK 0001300622 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 3,133 shares Expires 2020-08-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option to purchase 3,133 STERIS ordinary shares, which is fully vested, was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 3,133 Old STERIS ordinary shares for $32.34 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. Read SEC document
March 05, 2020 Filed Mar 6, 2020 21:31 UTC	STERIS plc STE · Entity 3228	Exercise / conversionOrdinary Shares	3,133	$32.34	$101,321.22	Disclosure SEC source: 0001209191-20-016928 · doc4.xml · nonDerivative · entry 1 Breeden Richard C · CIK 0001300622 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,681 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
August 06, 2019 Filed Aug 8, 2019 20:26 UTC	STERIS plc STE · Entity 3228	GrantCareer Restricted Stock Units · Derivative	525	$152.32	$79,968.00	Disclosure SEC source: 0001209191-19-045106 · doc4.xml · derivative · entry 3 Breeden Richard C · CIK 0001300622 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,923 Underlying: Ordinary Shares · 525 shares Expires not disclosed F2 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F4 · price: These Career Restricted Stock Units were issued to the Reporting Person in lieu of fees of $80,000. F3 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F3 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document
August 06, 2019 Filed Aug 8, 2019 20:26 UTC	STERIS plc STE · Entity 3228	GrantCareer Restricted Stock Units · Derivative	682	$0.00	$0.00	Disclosure SEC source: 0001209191-19-045106 · doc4.xml · derivative · entry 2 Breeden Richard C · CIK 0001300622 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,398 Underlying: Ordinary Shares · 682 shares Expires not disclosed F2 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F3 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F3 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document
August 06, 2019 Filed Aug 8, 2019 20:26 UTC	STERIS plc STE · Entity 3228	GrantDirector Stock Option (right to buy) · Derivative	3,098	$0.00 Strike: $152.32	$0.00	Disclosure SEC source: 0001209191-19-045106 · doc4.xml · derivative · entry 1 Breeden Richard C · CIK 0001300622 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,098 Underlying: Ordinary Shares · 3,098 shares Expires 2029-08-06 F1 · derivative.exercise_date: These nonqualified stock options are fully vested and are exercisable immediately. Read SEC document
March 28, 2019 Filed Mar 28, 2019 18:56 UTC	STERIS plc STE · Entity 3228	GrantCareer Restricted Stock Units · Derivative	12,716	$0.00	$0.00	Disclosure SEC source: 0001209191-19-021596 · doc4.xml · derivative · entry 12 Breeden Richard C · CIK 0001300622 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,716 Underlying: Ordinary Shares · 12,716 shares Expires not disclosed F13 · derivative.exercise_price: These career restricted stock units were assumed by STERIS pursuant to the Scheme and converted to career restricted stock units of STERIS representing the right to receive 12,716 STERIS ordinary shares. These career restricted stock units are fully vested and will be settled in STERIS ordinary shares six months after the cessation of the reporting person's board service, subject to the terms and conditions of the award agreement. F13 · derivative.exercise_date: These career restricted stock units were assumed by STERIS pursuant to the Scheme and converted to career restricted stock units of STERIS representing the right to receive 12,716 STERIS ordinary shares. These career restricted stock units are fully vested and will be settled in STERIS ordinary shares six months after the cessation of the reporting person's board service, subject to the terms and conditions of the award agreement. F13 · derivative.expiration_date: These career restricted stock units were assumed by STERIS pursuant to the Scheme and converted to career restricted stock units of STERIS representing the right to receive 12,716 STERIS ordinary shares. These career restricted stock units are fully vested and will be settled in STERIS ordinary shares six months after the cessation of the reporting person's board service, subject to the terms and conditions of the award agreement. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.